The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting.
Obi S, Sato T, Sato S, Kanda M, Tokudome Y, Kojima Y, Suzuki Y, Hosoda K, Kawai T, Kondo Y, Isomura Y, Ohyama H, Nakagomi K, Ashizawa H, Miura Y, Amano H, Mochizuki H, Omata M.
Obi S, et al. Among authors: nakagomi k.
Hepatol Int. 2019 Mar;13(2):199-204. doi: 10.1007/s12072-019-09929-4. Epub 2019 Jan 22.
Hepatol Int. 2019.
PMID: 30671808